Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa-Reference-Cited by-同舟云学术

Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa

Published:2023-07 Issue:7 Volume:31 Page:2028-2041
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Occelli Laurence M.,Zobel Lena,Stoddard Jonathan,Wagner Johanna,Pasmanter Nathaniel,Querubin Janice,Renner Lauren M.,Reynaga Rene,Winkler Paige A.,Sun Kelian,Marinho Luis Felipe L.P.,O’Riordan Catherine R.,Frederick Amy,Lauer Andreas,Tsang Stephen H.,Hauswirth William W.,McGill Trevor J.,Neuringer Martha,Michalakis Stylianos,Petersen-Jones Simon M.

Funder

Oregon National Primate Research Center

National Institutes of Health

University of Utah

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial;Russell;Lancet,2017

2. Inherited retinal diseases: therapeutics, clinical trials and end points-A review;Georgiou;Clin. Exp. Ophthalmol.,2021

3. Data services and software for identifying genes and mutations causing retinal degeneration;Daiger;Invest. Ophthalmol. Vis. Sci.,1998

4. Retinitis pigmentosa;Hartong;Lancet,2006

5. Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod cGMP-gated channel in a family with autosomal recessive retinitis pigmentosa;Bareil;Hum. Genet.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic and Phenotypic Characterization of a Cohort of Patients Affected by Rod Cyclic Nucleotide Channel-Associated Retinitis Pigmentosa;Ophthalmic Research;2024-05-07

2. Manifestations of systemic disease in the retina and fundus of cats and dogs;Frontiers in Veterinary Science;2024-02-20